Baseline characteristics | |
---|---|
Sex, male/female, n (%) | 22/8 (73/27) |
Median age (IQR) | 39 (34–45) |
Median body mass index (kg/m2) (IQR) | 21.4 (20.4–23.5) |
HIV positive, n (%) | 29 (97) |
CD4 T-cell count (cells/mm3)a | 192 (109–300) |
ART status | |
ART not yet started, number (%) | 12 (40) |
ART < 6 months, n (%) | 10 (33) |
ART > 6 months, n (%) | 7 (23) |
KS staging | |
Skin lesions T0, n (%) | 10 (33) |
Skin lesions T1, n (%) | 20 (67) |
Oral lesions, n (%) | 17 (60) |
Leg edema, n (%)b | 20 (67) |
CXR suggestive for KS lung involvement, n (%)c | 10 (40) |
Ultrasound features (n, %)d | |
---|---|
Lymphadenopathy | 20 (67) |
Inguinal lymphadenopathy | 20 (67) |
Abdominal lymphadenopathy | 3 (10) |
Axillary lymphadenopathy | 1 (3) |
Effusions | 8 (27) |
Pleural effusion | 6 (20) |
Ascites | 4 (13) |
Pericardial effusion | 1 (3) |
Echogenic focal liver lesions | 6 (20) |
Splenomegalye | 3 (10) |
Focal spleen lesions | 3 (10) |
Sponge pattern of splenic vasculature | 3 (10) |
Echogenic portal fields | 2 (7) |
Hepatomegaly | 1 (3) |